Lynn Kramer

Biography

Vice President
Chief Clinical Officer

Lynn Kramer

  • Mar. 2005

    Senior Vice President, Clinical Development and Medical Affairs and Chief Medical Officer, PAR Pharmaceuticals, Inc.

  • May. 2007

    Joined Eisai Medical Research Inc. (currently Eisai Inc.)

  • Jul. 2009

    President, Neuroscience Product Creation Unit

  • Dec. 2012

    President, Neuroscience & General Medicine Product Creation Unit

  • Apr. 2013

    Vice President (current)

  • Apr. 2013

    Chief Clinical Officer, Eisai Product Creation Systems

  • May. 2015

    Chief Medical Officer, Eisai Global Neurology Business Unit

  • Apr. 2016

    Chief Clinical Officer, Neurology Business Group

  • Apr. 2016

    Chief Medical Officer, Neurology Business Group

  • Jul. 2022

    Chief Clinical Officer, Alzheimer’s Disease and Brain Health

  • Aug. 2023

    Chief Clinical Officer (current)